AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2020
Aug 5, 2020
30718_dirs_2020-08-05_b76f04d5-cb1f-45a7-85c8-aa20a946c6b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2020-08-03
Reporting Person: Bushman Julie L (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-03 | Common Stock | A | 89.00 | $0.00 | Acquired | 89.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-08-03 | Stock Option (Right to Buy) | $278.87 | A | 361.00 | Acquired | 2030-07-31 | Common Stock (361.00) | Direct |
More from BIO-TECHNE Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Board/Management Information
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4